DrugPatentWatch Database Preview
DICLOFENAC POTASSIUM Drug Profile
When do Diclofenac Potassium patents expire, and when can generic versions of Diclofenac Potassium launch?
Diclofenac Potassium is a drug marketed by Bionpharma Inc, Par Form, Apotex, Casi Pharms Inc, Mylan, Sandoz, Sun Pharm Industries, Teva, and Watson Labs Teva. and is included in nine NDAs.
The generic ingredient in DICLOFENAC POTASSIUM is diclofenac potassium. There are forty-seven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the diclofenac potassium profile page.
Summary for DICLOFENAC POTASSIUM
Pharmacology for DICLOFENAC POTASSIUM
| Ingredient-type | Nonsteroidal Anti-inflammatory Compounds |
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
| Physiological Effect | Decreased Prostaglandin Production |
Synonyms for DICLOFENAC POTASSIUM
| 15307-81-0 |
| 15307-86-5 (Parent) |
| 2-((2,6-dichlorophenyl)amino)benzeneacetic acid, monopotassium salt |
| AB0013318 |
| AC-18735 |
| AK163133 |
| AKOS015889752 |
| AKOS015994733 |
| AN-8291 |
| Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, monopotassium salt |
| C14H10Cl2KNO2 |
| C14H10Cl2NO2.K |
| Cambia |
| Cambia (TN) |
| Cataflam |
| Cataflam (TN) |
| CGP 45840B |
| CGP-45840B |
| CHEBI:4508 |
| CHEMBL1200804 |
| D00903 |
| Diclofenac potassium (USAN) |
| Diclofenac potassium [USAN:USP] |
| Diclofenac potassium [USAN] |
| Diclofenic potassium |
| DR001603 |
| DTXSID30165212 |
| FT-0603076 |
| H866 |
| HMS3656D18 |
| I01-3215 |
| KS-5037 |
| KXZOIWWTXOCYKR-UHFFFAOYSA-M |
| L4D5UA6CB4 |
| LS-173441 |
| MolPort-005-937-655 |
| Potassium (o-(2,6-dichloroanilino)phenyl)acetate |
| potassium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate |
| potassium 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate |
| potassium 2-[2-(2,6-dichloroanilino)phenyl]acetate |
| potassium;2-[2-(2,6-dichloroanilino)phenyl]acetate |
| PubChem5895 |
| s3062 |
| SC-01315 |
| SCHEMBL40784 |
| ST51051764 |
| UNII-L4D5UA6CB4 |
| Voltfast |
| Zipsor |
| Zipsor (TN) |
US Patents and Regulatory Information for DICLOFENAC POTASSIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bionpharma Inc | DICLOFENAC POTASSIUM | diclofenac potassium | CAPSULE;ORAL | 204648-001 | Feb 23, 2016 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Sun Pharm Industries | DICLOFENAC POTASSIUM | diclofenac potassium | TABLET;ORAL | 075470-001 | Feb 21, 2002 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Casi Pharms Inc | DICLOFENAC POTASSIUM | diclofenac potassium | TABLET;ORAL | 075229-001 | Nov 20, 1998 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Teva | DICLOFENAC POTASSIUM | diclofenac potassium | TABLET;ORAL | 075219-001 | Aug 6, 1998 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
